CareLit · DOI-Nachweis · Ultraschall in der Medizin - European Journal of Ultrasound
Assessment of tumor response to antiangiogenic chemotherapy for hepatic breast cancer metastases: Imaging of the malignant neoangiogenesis with perfusion ct vs. contrast-enhanced ultrasound (CEUS)
DOI 10.1055/s-2007-988979
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Savelli, S Pascoli, M Atzori, P Ialongo, G Regine, S Cisternino, LM Porfiri, L Adami
ZeitschriftUltraschall in der Medizin - European Journal of Ultrasound
Ausgabe10/2007
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objectives: Malignant angiogenesis affects tumor growth, local expansion and metastasis. Antiangiogenic chemotherapies act to reduce tumoral cell growth acting as angiogenesis inhibitor for endothelial cells. Objective tumor response is a common endpoint to evaluate the efficacy of anticancer agents. World Health Organization (WHO) or Response Evaluation Criteria in Solid Tumors Group (RECIST) criteria are not appro…
Zitieren
Zitierempfehlung
S Savelli, S Pascoli, M Atzori, P Ialongo, G Regine, S Cisternino, LM Porfiri, L Adami (2007) Assessment of tumor response to antiangiogenic chemotherapy for hepatic breast cancer metastases: Imaging of the malignant neoangiogenesis with perfusion ct vs. contrast-enhanced ultrasound (CEUS). Ultraschall in der Medizin - European Journal of Ultrasound (10). https://doi.org/10.1055/s-2007-988979
Mit CareLit weiterarbeiten